Loading company details...
Beta
Latest Form 4 (Oct 7, 2026): Donald W. DeGolyer (Director): Sale of 17,800 shares, $126.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 7, 2026 | Donald W. DeGolyer | Sale | 17,800 | $126.2K |
| Oct 5, 2026 | Paul Anthony Williams, SVP, Products Business | Sale | 3,000 | $19.6K |
| Jul 2, 2026 | Paul Anthony Williams, SVP, Products Business | Sale | 3,000 | $25.2K |
| Jun 10, 2026 | Paul Anthony Williams, SVP, Products Business | Tax Withholding | 694 | $5.6K |
| Jun 10, 2026 | Richard S. Lindahl, EVP, Chief Financial Officer | Tax Withholding | 3,964 | $31.7K |
| Jun 10, 2026 | Coleen Glessner, EVP, Quality & Ethics, and CPL | Tax Withholding | 2,018 | $16.1K |
| Jun 10, 2026 | William Hartzel, SVP, Bioservices | Tax Withholding | 1,741 | $13.9K |
| May 4, 2026 | Sujata Tyagi Dayal | Grant/Award | 25,344 | n/a |
| May 4, 2026 | Donald W. DeGolyer | Grant/Award | 25,344 | n/a |
| May 4, 2026 | Keith Katkin | Grant/Award | 25,344 | n/a |